Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and Sepsis
Authors:
- 1 December 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 61 (5) , e202114922
Abstract
Sepsis, characterized with high risk of life‐threatening organ dysfunction, represents a major cause of health loss and the World Health Organization (WHO) labelled sepsis as the most urgent unmet medical need in 2017. The emerging biological understanding of the role of RIPK1 in sepsis has opened up an exciting opportunity to explore potent and selective RIPK1 inhibitors as an effective therapeutic strategy for SIRS and sepsis therapy. Herein, we have synthesized a class of highly potent dual‐mode RIPK1 inhibitors occupying both the allosteric and the ATP binding pockets, exemplified by compound 21 (ZB‐R‐55) which is about 10‐fold more potent than GSK2982772, and exhibits excellent kinase selectivity, good oral pharmacokinetics and good therapeutic effects in the LPS‐induced sepsis model, suggesting that compound ZB‐R‐55 is a highly promising preclinical candidate.Keywords
Funding Information
- National Natural Science Foundation of China (81973166, 91753207, 81773568)
- Science and Technology Commission of Shanghai Municipality (18431907100, 18430712500, 20JC1418000)
This publication has 28 references indexed in Scilit:
- Necroptosis and its role in inflammationNature, 2015
- Regulated necrosis: the expanding network of non-apoptotic cell death pathwaysNature Reviews Molecular Cell Biology, 2014
- Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with NecroptosisACS Medicinal Chemistry Letters, 2013
- Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar TyphimuriumNature Immunology, 2012
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activationCell Death & Differentiation, 2012
- RIP Kinase-Dependent Necrosis Drives Lethal Systemic Inflammatory Response SyndromeImmunity, 2011
- The Dual Functions of Receptor Interacting Protein 1 in Fas-Induced Hepatocyte Death During SepsisShock, 2011
- Molecular mechanisms of necroptosis: an ordered cellular explosionNature Reviews Molecular Cell Biology, 2010
- Identification of RIP1 kinase as a specific cellular target of necrostatinsNature Chemical Biology, 2008
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injuryNature Chemical Biology, 2005